000 01149 a2200313 4500
005 20250516033251.0
264 0 _c20110621
008 201106s 0 0 eng d
022 _a1528-4336
024 7 _a10.1310/hct1202-118
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aWen, Ying
245 0 0 _aInterferon successfully inhibited refractory cytomegalovirus infection and resulted in CD4+ T-cells increase in a patient with AIDS.
_h[electronic resource]
260 _bHIV clinical trials
_c
300 _a118-20 p.
_bdigital
500 _aPublication Type: Case Reports; Letter
650 0 4 _aAIDS-Related Opportunistic Infections
_xdrug therapy
650 0 4 _aAntiretroviral Therapy, Highly Active
650 0 4 _aCD4 Lymphocyte Count
650 0 4 _aCytomegalovirus Infections
_xdrug therapy
650 0 4 _aHumans
650 0 4 _aInterferon alpha-2
650 0 4 _aInterferon-alpha
_xtherapeutic use
650 0 4 _aMale
650 0 4 _aRecombinant Proteins
700 1 _aLiu, Pei
773 0 _tHIV clinical trials
_gvol. 12
_gno. 2
_gp. 118-20
856 4 0 _uhttps://doi.org/10.1310/hct1202-118
_zAvailable from publisher's website
999 _c20764091
_d20764091